Shares of ResMed Inc. RMD rallied 3.82% to $213.00 Monday, on what proved to be an all-around rough trading session for the ...
SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback